Monoclonal antibody and viral vector manufacture share similarities, but vector scale up faces unique challenges. Scale up in gene therapy manufacturing currently revolves around viral vector scale up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback